Pharmazeutika Dänemark

Zealand Pharma News

Aktie
WKN:  A0YJW7 ISIN:  DK0060257814 US-Symbol:  ZLDPF
86,70 €
+5,20 €
+6,38%
31.05.24 20:56:12
Handeln Depot/Watchlist
Aktienanzahl *
58,35 Mio.
Marktkapitalisierung *
5,06 Mrd. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 19.05.2023

Zealand Pharma News

26.02.24 - wallstreet:online Zentralredaktion
Abnehmmittel : Zealand Pharma-Aktie geht steil! Bekommt die Abnehmspritze-Ozempic Konkurrenz?
Bekommt die Abnehmspritze-​Ozempic von Norvo Nordisk und Eli Lilly Konkurrenz? Die Diätspritze von Zealand Pharma und Boehringer Ingelheim wirkt nicht nur gegen ...
13.12.23 - wallstreet:online Zentralredaktion
Novos kleiner Bruder: Abnehmspritze: Diese Pharma-Aktie lief in 2023 noch besser als Novo Nordisk
Das Geschäft mit Übergewicht-​Medikamenten boomt. Zu den Platzhirschen Novo Nordisk und Eli Lilly gesellen sich immer mehr Konkurrenten, auch kleinere Unternehmen. ...
11.08.22 - PLX
Zealand Pharma Half Year Operating Result DKK -539.2 Million
(PLX AI) – Zealand Pharma half year revenue DKK 43.5 million.
01.06.22 - PLX
Zealand Pharma to Raise DKK 275 Million at DKK 95 per Share
(PLX AI) – Zealand Pharma announces directed issue and private placement corresponding to approx. 6.6 % of existing share capital. • Zealand Pharma expects gross proceeds DKK ...
19.05.22 - PLX
Zealand Pharma Says Phase 3 Dasiglucagon Trial Succeeds; Will Apply for FDA Approval This Year
(PLX AI) – Zealand Pharma Announces Positive Results from Phase 3 Trial of Dasiglucagon in Pediatric Patients with Congenital Hyperinsulinism (CHI) • Zealand Pharma says ...
12.05.22 - PLX
Zealand Pharma Q1 Operating Result DKK -302 Million vs. Estimate DKK -298 Million
(PLX AI) – Zealand Pharma Q1 revenue DKK 15.1 million vs. estimate DKK 64 million.
10.03.22 - PLX
Zealand Pharma FY Operating Result DKK -1,052.4 Million vs. Estimate DKK -917 Million
(PLX AI) – Zealand Pharma FY revenue DKK 292.6 million vs. estimate DKK 277 million.
15.02.22 - PLX
Zealand Pharma Expects Phase 3 Dasiglucagon Results in Q2
(PLX AI) – Zealand Pharma completes Enrollment in Phase 3 Trial of Dasiglucagon in Children with Congenital Hyperinsulinism (CHI). • Zealand Pharma says Dasiglucagon top-line ...
26.11.21 - PLX
Zealand Pharma Short Position Initiated By Voleon Capital Management
(PLX AI) – Voleon Capital Management now holds a short position at 0.5% in shares issued by Zealand Pharma.
23.11.21 - PLX
Zealand Pharma Short Position Increased By Armistice Capital
(PLX AI) – Armistice Capital now holds a short position at 0.71% in shares issued by Zealand Pharma, up from 0.61% previously.
22.11.21 - PLX
Zealand Pharma Says Dapiglutide Phase 1b Trial Successful
(PLX AI) – Zealand Pharma announces successful outcome of Phase 1b clinical trial with GLP1-GLP2 dual receptor agonist, dapiglutide. • Dapiglutide was assessed to be safe and ...
11.11.21 - PLX
Zealand Pharma Cuts Outlook for Commercial Product Revenue After Lower Zegalogue Sales
(PLX AI) – Zealand Pharma says net product revenue from the sales of commercial products is expected to be DKK 190 million +/- 10% for the full year. • This is a decrease of DKK 30 ...
11.11.21 - PLX
Zealand Pharma 9-Month Operating Result DKK -762.6 Million vs. Estimate DKK -848 Million
(PLX AI) – Zealand Pharma 9-month revenue DKK 238.6 million vs. estimate DKK 202 million.
04.11.21 - PLX
Zealand Pharma Short Position Reduced By WorldQuant
(PLX AI) – WorldQuant now holds a short position at 0.79% in shares issued by Zealand Pharma, down from 0.88% previously.
28.10.21 - PLX
Zealand Pharma Short Position Reduced By WorldQuant
(PLX AI) – WorldQuant now holds a short position at 0.88% in shares issued by Zealand Pharma, down from 0.99% previously.
08.10.21 - PLX
Zealand Pharma Short Position Increased By WorldQuant
(PLX AI) – WorldQuant now holds a short position at 1.0% in shares issued by Zealand Pharma, up from 0.91% previously.
28.09.21 - PLX
Zealand Pharma Short Position Increased By WorldQuant
(PLX AI) – WorldQuant now holds a short position at 0.91% in shares issued by Zealand Pharma, up from 0.82% previously.
20.09.21 - PLX
Zealand Pharma Short Position Initiated By Arrowstreet Capital Partnership
(PLX AI) – Arrowstreet Capital Partnership now holds a short position at 0.5% in shares issued by Zealand Pharma.
20.09.21 - PLX
Zealand Pharma Short Position Increased By WorldQuant
(PLX AI) – WorldQuant now holds a short position at 0.82% in shares issued by Zealand Pharma, up from 0.7% previously.
15.09.21 - PLX
Zealand Pharma Short Position Increased By WorldQuant
(PLX AI) – WorldQuant now holds a short position at 0.7% in shares issued by Zealand Pharma, up from 0.62% previously.

Newssuche

Videos

29.05.24
Technical Trading: DAX Long Chance kurzfristig
DAX Long Typ: Turbo Open End WKN: VD5FWS Hebel: 28 Laufzeit: OpenEnd Einstieg: Market ... Mehr »